10x Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	473.97	344.07	359.28	219.75	587.45
Short-Term Investments	49.44	49.34	29.41	212.87	1.03
Cash & Short-Term Investments	523.41	393.4	388.7	432.62	588.48
Cash Growth	33.05%	1.21%	-10.15%	-26.48%	-13.48%
Accounts Receivable	47.01	87.86	114.83	104.21	85.25
Other Receivables	35.48	0.61	-	-	-
Total Trade Receivables	82.49	88.47	114.83	104.21	85.25
Inventory	56.34	83.11	73.71	81.63	59.97
Other Current Assets	22.21	19.41	18.79	16.58	13.9
Total Current Assets	684.45	584.39	596.02	635.04	747.59
Net Property, Plant & Equipment	287.16	309.94	344.93	359.21	230.41
Other Intangible Assets	62.33	15.67	16.62	22.86	25.4
Goodwill	4.51	4.51	4.51	4.51	4.51
Other Long-Term Assets	2.91	4.13	3.06	7.37	10.92
Total Assets	1,041	918.64	965.14	1,029	1,019
Accounts Payable	12.73	12.91	15.74	21.6	17.35
Accrued Expenses	82.47	74.78	86.75	92.45	82.54
Current Portion of Leases	10.99	9.29	11.52	9.04	5.13
Unearned Revenue	23.9	20.66	13.15	7.87	5.34
Other Current Liabilities	23.36	-	-	-	-
Total Current Liabilities	153.45	117.63	127.16	130.96	110.36
Long-Term Leases	73.38	73.33	83.85	86.14	76.85
Other Long-Term Liabilities	18.21	17.54	13.09	6.14	14.05
Total Long-Term Liabilities	91.59	90.87	96.94	92.28	90.9
Total Liabilities	245.04	208.5	224.1	223.24	201.26
Common Stock	0	0	0	0	0
Additional Paid-in Capital	2,307	2,178	2,026	1,839	1,681
Accumulated Other Comprehensive Income	0.23	-0.49	-0.43	-4.34	0.02
Retained Earnings	-1,511	-1,467	-1,284	-1,029	-863.32
Shareholders' Equity	796.33	710.13	741.04	805.74	817.57
Total Liabilities & Equity	1,041	918.64	965.14	1,029	1,019
Total Debt	84.36	82.61	95.37	95.18	81.98
Net Cash (Debt)	439.05	310.79	293.33	337.44	506.5
Net Cash Growth	41.27%	5.95%	-13.07%	-33.38%	-17.94%
Net Cash Per Share	3.52	2.58	2.50	2.96	4.59
Book Value	796.33	710.13	741.04	805.74	817.57
Book Value Per Share	6.38	5.90	6.32	7.08	7.41
Tangible Book Value	729.49	689.95	719.92	778.37	787.66
Tangible Book Value Per Share	5.85	5.73	6.14	6.84	7.14

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q